These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 37331250)
1. Difference in acute and chronic stage ischemic stroke metabolic markers with controls. Sidorov EV; Rout M; Xu C; Jordan L; Fields E; Apple B; Smith K; Gordon D; Chainakul J; Sanghera DK J Stroke Cerebrovasc Dis; 2023 Aug; 32(8):107211. PubMed ID: 37331250 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Acute and Chronic Stage Ischemic Stroke Metabolome with Controls. Sidorov EV; Rout M; Xu C; Larsen J; Fields E; Apple B; Smith K; Gordon D; Chainakul J; Sanghera D Res Sq; 2023 Jan; ():. PubMed ID: 36778444 [TBL] [Abstract][Full Text] [Related]
3. Global Metabolomic Profiling Reveals Disrupted Lipid and Amino Acid Metabolism Between the Acute and Chronic Stages of Ischemic Stroke. Sidorov EV; Xu C; Garcia-Ramiu J; Blair A; Ortiz-Garcia J; Gordon D; Chainakul J; Sanghera DK J Stroke Cerebrovasc Dis; 2022 Apr; 31(4):106320. PubMed ID: 35104745 [TBL] [Abstract][Full Text] [Related]
4. Potential Metabolite Biomarkers for Acute Versus Chronic Stage of Ischemic Stroke: A Pilot Study. Sidorov E; Bejar C; Xu C; Ray B; Reddivari L; Chainakul J; Vanamala JKP; Sanghera DK J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104618. PubMed ID: 31973907 [TBL] [Abstract][Full Text] [Related]
5. Discovery and validation of circulating stroke metabolites by NMR-based analyses using patients from the MISS and UK Biobank. Rout M; Vaughan A; Blair A; Stavrakis S; Sidorov EV; Sanghera DK Neurochem Int; 2023 Oct; 169():105588. PubMed ID: 37499945 [TBL] [Abstract][Full Text] [Related]
6. Novel Metabolites as Potential Indicators of Ischemic Infarction Volume: a Pilot Study. Sidorov EV; Bejar C; Xu C; Ray B; Gordon D; Chainakul J; Sanghera DK Transl Stroke Res; 2021 Oct; 12(5):778-784. PubMed ID: 33215346 [TBL] [Abstract][Full Text] [Related]
7. Novel metabolic biomarkers for the diagnosis of acute ischemic stroke. Tang Z; Xu B; Wang J; Wang W; Sha S; Sun Y Biomark Med; 2024; 18(17-18):727-737. PubMed ID: 39235047 [TBL] [Abstract][Full Text] [Related]
8. GC-MS-based metabolomics identifies an amino acid signature of acute ischemic stroke. Wang D; Kong J; Wu J; Wang X; Lai M Neurosci Lett; 2017 Mar; 642():7-13. PubMed ID: 28111353 [TBL] [Abstract][Full Text] [Related]
9. Integrating serum proteomics and metabolomics to compare the common and distinct features between acute aggressive ischemic stroke (APIS) and acute non-aggressive ischemic stroke (ANPIS). Lai M; Zhang X; Zhou D; Zhang X; Zhu M; Liu Q; Zhang Y; Wang D J Proteomics; 2022 Jun; 261():104581. PubMed ID: 35421619 [TBL] [Abstract][Full Text] [Related]
10. Serum metabolic signatures for Alzheimer's Disease reveal alterations in amino acid composition: a validation study. Nielsen JE; Andreassen T; Gotfredsen CH; Olsen DA; Vestergaard K; Madsen JS; Kristensen SR; Pedersen S Metabolomics; 2024 Jan; 20(1):12. PubMed ID: 38180611 [TBL] [Abstract][Full Text] [Related]
11. Global metabolomics analysis of serum from humans at risk of thrombotic stroke. Khan A; Shin MS; Jee SH; Park YH Analyst; 2020 Mar; 145(5):1695-1705. PubMed ID: 31895365 [TBL] [Abstract][Full Text] [Related]
12. A pilot metabolic profiling study in serum of patients with chronic kidney disease based on (1) H-NMR-spectroscopy. Qi S; Ouyang X; Wang L; Peng W; Wen J; Dai Y Clin Transl Sci; 2012 Oct; 5(5):379-85. PubMed ID: 23067349 [TBL] [Abstract][Full Text] [Related]
13. Serum metabolomic patterns in young patients with ischemic stroke: a case study. Liu J; Yuan J; Zhao J; Zhang L; Wang Q; Wang G Metabolomics; 2021 Feb; 17(2):24. PubMed ID: 33554271 [TBL] [Abstract][Full Text] [Related]
15. Discovery of Metabolite Biomarkers for Acute Ischemic Stroke Progression. Liu P; Li R; Antonov AA; Wang L; Li W; Hua Y; Guo H; Wang L; Liu P; Chen L; Tian Y; Xu F; Zhang Z; Zhu Y; Huang Y J Proteome Res; 2017 Feb; 16(2):773-779. PubMed ID: 28092160 [TBL] [Abstract][Full Text] [Related]
16. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients. Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896 [TBL] [Abstract][Full Text] [Related]
17. Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry. Callejón-Leblic B; Pereira-Vega A; Vázquez-Gandullo E; Sánchez-Ramos JL; Gómez-Ariza JL; García-Barrera T Biochimie; 2019 Feb; 157():111-122. PubMed ID: 30439409 [TBL] [Abstract][Full Text] [Related]
18. Integration of 16S rRNA gene sequencing and LC/MS-based metabolomic analysis of early biomarkers of acute ischaemic stroke in Tibetan miniature pigs. Guan Y; Liu T; Xu F; Xie S; Gu W; Bie Y J Microbiol Methods; 2023 Dec; 215():106846. PubMed ID: 37863204 [TBL] [Abstract][Full Text] [Related]
19. ¹H NMR-based metabolic profiling of human rectal cancer tissue. Wang H; Wang L; Zhang H; Deng P; Chen J; Zhou B; Hu J; Zou J; Lu W; Xiang P; Wu T; Shao X; Li Y; Zhou Z; Zhao YL Mol Cancer; 2013 Oct; 12(1):121. PubMed ID: 24138801 [TBL] [Abstract][Full Text] [Related]